Stocks to Wtach: Karyopharm Therapeutics, Mkdwell, Advanced Biomed

Dow Jones
07/18
 

Karyopharm Therapeutics said its CEO will receive more than $1.7 million under a new cash retention program for top executives. Shares fell 21% to $7.50 in after-hours trading on Friday.

MKDWELL agreed to purchase the parent company of smart-home and Internet-of-Things products developer Landvision Technology for an aggregate consideration of $240 million. The stock was up 6% to $11.83 after the bell.

Advanced Biomed terminated a purchase agreement which gave it the right to issue and sell $25 million worth of shares to an investor. Shares were up 35% to $6.80.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

July 17, 2026 18:31 ET (22:31 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10